A randomised double blind controlled trial of BCNU [carmustine] as second line therapy in metastatic oesophago [oesophageal]-gastric, colorectal and pancreatic cancer
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Carmustine (Primary)
- Indications Colorectal cancer; Gastric cancer; Oesophageal cancer; Pancreatic cancer
- Focus Therapeutic Use
- 06 Aug 2009 Actual initiation date (Jan 1995 ) added as reported by ISRCTN: Current Controlled Trials.
- 16 Feb 2006 New trial record.